A positive view on a negative trial with DOAC after TAVR

3' education - Apr. 19, 2022 - Megan Coylewright, MD - Chattanooga, TN, USA

Educational information

This video was recorded at the Congress of the American College of Cardiology (ACC) 2022.

Faculty

Megan Coylewright is interventional cardiologist at the Erlanger Health System in Chattanooga, TN, VS.

Disclosures

This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.

Read our summary of the ADAPT-TAVR study

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.